WHWK Whitehawk Therapeutics, Inc. - Common Stock
$5,00
Cena · Sie 25, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$2–$5
87% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$8
+50% upside
P/E (TTM)
-15.2
ROE
-13.4%
Marża Zysku Netto
-288.3%
WHWK Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.00
Kapitalizacja Rynkowa
$236M
P/E (TTM)
-15.2
EPS (TTM)
$-0.33
Przychody (TTM)
$7M
Stopa dywidendy
—
ROE
-13.4%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $5
WHWK Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$7M
2018-12-31
→
2025-12-31
EPS
$-0.33
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-98M
2018-12-31
→
2025-12-31
Marże
-288.3%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
WHWK
Mediana porównawcza
P/E (TTM)
-15.2
1.2
P/S (TTM)
33.0
6.3
P/B
1.7
1.6
Price / FCF (Cena / FCF)
-2.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
WHWK
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-1601.1%
—
Net Profit Margin (Marża Zysku Netto)
-288.3%
-312.6%
ROA
-18.6%
-56.8%
ROE
-13.4%
-83.3%
ROIC
-83.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
WHWK
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
10.3
8.5
Quick Ratio (Wskaźnik Szybkości)
10.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
WHWK
Mediana porównawcza
Revenue YoY (Przychody R/R)
-72.5%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-22.3%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
-12.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
WHWK
Mediana porównawcza
WHWK Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 4 28,6%
- Kup 6 42,9%
- Trzymaj 4 28,6%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-22
Mediana
$7.50
Teraz
$5.00
Niski
$4.00
Wysoki
$10.00
Średni cel
$7.50
+50,2%
Średnia cel
$7.50
+50,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.25%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.20 | $-0.30 | 0.10% |
| 31 marca 2026 | $-0.32 | $-0.36 | 0.04% |
| 31 grudnia 2025 | $-0.34 | $-0.16 | -0.18% |
| 30 września 2025 | $-0.26 | $0.07 | -0.33% |
| 30 czerwca 2025 | $-0.76 | $0.50 | -1.3% |
| 31 marca 2025 | $-0.37 | $-0.47 | 0.10% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| NBP | — | — | — | — | — | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| CNXU | — | — | — | — | — | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| HUMA | — | — | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Cost of Revenue | $760.0K | $3M | $3M | $1M | $0 | · | · | · | |
| R&D Expense | $91M | $51M | $49M | $33M | $20M | $15M | $13M | $18M | |
| SG&A Expense | $30M | $37M | $45M | $40M | $19M | $2M | $10M | $13M | |
| Operating Expenses | $122M | $93M | $96M | $78M | $112M | $17M | $24M | $31M | |
| Operating Income | $-114M | $-67M | $-72M | $-63M | $-111M | $-3M | $-24M | $-11M | |
| Interest Expense | · | · | $231.0K | $230.0K | $665.0K | $815.0K | · | · | |
| Interest Income | $6M | $4M | $6M | $2M | $13.0K | $41.0K | · | · | |
| Other Non-op | $94M | $4M | $6M | $2M | $1M | $-927.0K | $1M | $784.6K | |
| Pretax Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $2.0K | $2.0K | · | · | |
| Net Income | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| EPS (Basic) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| EPS (Diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 | · | · | · | |
| Shares (Basic) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| Shares (Diluted) | 61,886,765 | 27,029,942 | 26,917,967 | 22,511,237 | 8,923,369 | · | · | · | |
| EBITDA | $-114M | $-67M | $-72M | $-63M | $-111M | $-6M | $-24M | $-11M |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $29M | $63M | $39M | $149M | $4M | $39M | $63M | |
| Short-term Investments | $108M | $19M | $46M | $134M | $0 | · | · | · | |
| Receivables | $0 | $6M | $5M | $2M | $0 | $14M | · | · | |
| Inventory | $0 | $5M | $6M | $2M | $0 | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $2M | $81.0K | $311.2K | $754.4K | |
| Other Current Assets | · | · | · | · | · | $2M | $734.8K | $615.7K | |
| Current Assets | $149M | $61M | $125M | $180M | $151M | $19M | $40M | $64M | |
| PP&E (Net) | $3.0K | $7M | $5M | $508.0K | $57.0K | $21.0K | $164.2K | $98.4K | |
| PP&E (Gross) | $377.0K | $7M | $5M | $609.0K | $87.0K | $512.1K | $493.0K | $409.6K | |
| Accum. Depreciation | $374.0K | $463.0K | $270.0K | $101.0K | $30.0K | $390.3K | $328.9K | $311.1K | |
| Intangibles | · | · | · | $0 | $4M | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2M | $2M | $2M | · | · | · | |
| Total Assets | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Accounts Payable | $917.0K | $2M | $6M | $4M | $6M | $2M | $439.8K | $595.7K | |
| Accrued Liabilities | $14M | $15M | $14M | $15M | $9M | $4M | · | · | |
| Current Liabilities | $15M | $17M | $26M | $19M | $15M | $30M | $3M | $5M | |
| Capital Leases | $0 | $565.0K | $833.0K | $1M | $474.0K | · | $67.4K | · | |
| Other Non-current Liabilities | $0 | $202.0K | $0 | · | $0 | $97.0K | · | · | |
| Total Liabilities | $15M | $18M | $27M | $26M | $22M | $31M | $3M | $5M | |
| Common Stock | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $4.1K | $4.1K | |
| Retained Earnings | $-353M | $-333M | $-269M | $-203M | $-143M | $-33M | $-142M | $-119M | |
| AOCI | $120.0K | $16.0K | $27.0K | $-115.0K | $0 | · | · | · | |
| Stockholders' Equity | $136M | $52M | $105M | $158M | $136M | $-12M | $-9M | $59M | |
| Liabilities + Equity | $151M | $70M | $132M | $184M | $158M | $19M | $40M | $64M | |
| Shares Outstanding | 47,145,719 | 24,681,000 | 24,554,000 | 24,435,000 | 20,895,000 | 2,542,358 | 40,588,004 | 40,588,004 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $193.0K | $169.0K | $159.0K | $105.0K | $9.0K | · | · | |
| Stock-based Comp | $10M | $11M | $12M | $10M | $2M | $139.0K | $1M | $3M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $87.0K | $95.0K | $0 | · | · | |
| Restructuring | $0 | $3M | $0 | · | · | · | · | · | |
| Other Non-cash | $-87M | $-7M | $-6M | $1M | $85M | · | · | · | |
| Operating Cash Flow | $-97M | $-60M | $-60M | $-50M | $-22M | $-13M | $-24M | $-6M | |
| CapEx | $552.0K | $2M | $4M | $444.0K | $46.0K | $19.0K | $237.0K | $37.9K | |
| Investing Cash Flow | $12M | $25M | $83M | $-133M | $25M | $-19.0K | $-237.0K | $-37.9K | |
| Stock Issued | · | · | · | $0 | $155M | $10M | · | $52M | |
| Net Stock Activity | · | · | · | $0 | $155M | $10M | · | $52M | |
| Dividends Paid | · | · | · | $0 | $4M | · | · | · | |
| Financing Cash Flow | $94M | $130.0K | $326.0K | $73M | $142M | $1M | · | $48M | |
| Net Change in Cash | $9M | $-34M | $24M | $-110M | $145M | $-12M | $-24M | $42M | |
| Free Cash Flow | $-98M | $-61M | $-64M | $-50M | $-22M | $-5M | $-24M | $-6M | |
| Levered FCF | · | · | $-64M | $-50M | $-23M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -42.4% | · | -55.5% | |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -28.8% | · | -51.6% | |
| Pretax Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.3% | · | · | · | |
| EBITDA Margin | -1600.0% | -258.9% | -294.7% | -410.9% | -9920.7% | -42.4% | · | -55.5% | |
| ROA | -18.6% | -62.8% | -41.5% | -35.4% | -124.6% | -10.2% | -44.7% | -24.4% | |
| ROE | -13.4% | -105.0% | -58.9% | -37.0% | -76.6% | -38.2% | -59.5% | -16.6% | |
| ROIC | -83.9% | -128.6% | -68.4% | -39.6% | -81.5% | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 | 24.0 | 11.9 | 11.7 | |
| Quick Ratio | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 | 22.8 | 11.6 | 11.5 | |
| Interest Coverage | · | · | -311.4 | -272.5 | -167.2 | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.3 | 0.2 | 0.1 | 0.0 | 0.4 | · | 0.5 | |
| Inventory Turnover | 0.3 | 0.5 | 0.7 | 1.4 | · | · | · | · | |
| Receivables Turnover | 2.4 | 4.6 | 6.6 | 16.3 | · | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -72.5% | 6.7% | 60.1% | 8.7% | 0.00% | · | · | · | |
| Revenue CAGR 3Y | -22.3% | 22.9% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -12.6% | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $26M | $24M | $15M | $14M | $14M | $0 | $20M | |
| Net Income TTM | $-21M | $-64M | $-66M | $-61M | $-110M | $-3M | $-23M | $-10M | |
| Market Cap | $114M | $78M | $50M | $314M | $505M | $695M | $380M | $1.03B | |
| P/E | -7.3 | -1.3 | -0.8 | -4.8 | -1.9 | · | · | · | |
| P/S | 16.0 | 3.0 | 2.0 | 20.6 | 36.0 | 49.6 | · | 51.3 | |
| P/B | 0.8 | 1.5 | 0.5 | 2.0 | 3.7 | 16.1 | 10.4 | 17.6 | |
| P / Tangible Book | 0.8 | 1.5 | 0.5 | 2.0 | 3.8 | · | · | · | |
| P / Cash Flow | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -129.0 | -15.9 | -178.2 | |
| P / FCF | -1.2 | -1.3 | -0.8 | -6.3 | -22.5 | -128.5 | -15.8 | -177.0 | |
| Dividend Yield | · | · | · | 0.00% | 0.87% | · | · | · | |
| Earnings Yield | -13.6% | -74.8% | -120.8% | -21.0% | -51.4% | · | · | · | |
| Payout Ratio | · | · | · | 0.00% | -4.0% | · | · | · | |
| Annual Payout | · | · | · | $0 | $4M | · | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $6M | $5M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $760.0K | $790.0K | $804.0K | $778.0K | $652.0K | $927.0K | $697.0K | $656.0K | $529.0K | $222.0K | $593.0K | |
| R&D Expense | $13M | $17M | $19M | $14M | $49M | $9M | $14M | $10M | $13M | $14M | $13M | $12M | $13M | $11M | $9M | $9M | |
| SG&A Expense | $5M | $6M | $6M | $5M | $6M | $13M | $11M | $7M | $8M | $11M | $10M | $11M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $18M | $24M | $25M | $20M | $55M | $22M | $26M | $21M | $22M | $25M | $24M | $24M | $26M | $23M | $21M | $19M | |
| Operating Income | $-18M | $-24M | $-25M | $-20M | $-55M | $-15M | $-19M | $-13M | $-16M | $-20M | $-18M | $-18M | $-20M | $-17M | $-15M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $58.0K | · | $58.0K | $58.0K | $58.0K | $56.0K | $58.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $791.0K | $676.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $620.0K | |
| Other Non-op | $1M | $1M | $2M | $2M | $2M | $88M | $676.0K | $867.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $562.0K | |
| Pretax Income | $-17M | $-22M | · | · | $-53M | $73M | · | · | · | · | $-16M | $-16M | $-18M | · | $-14M | $-14M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-9.0K | $0 | |
| Net Income | $-17M | $-22M | $-23M | $-18M | $-53M | $73M | $-18M | $-13M | $-15M | $-18M | $-16M | $-16M | $-18M | $-15M | $-14M | $-14M | |
| EPS (Basic) | $-0.20 | $-0.32 | $-1.15 | $-0.26 | $-0.76 | $1.84 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| EPS (Diluted) | $-0.20 | $-0.32 | $-1.14 | $-0.26 | $-0.76 | $1.83 | $-0.68 | $-0.46 | $-0.54 | $-0.68 | $-0.60 | $-0.60 | $-0.67 | $-0.57 | $-0.48 | $-0.68 | |
| Shares (Basic) | 82,886,196 | 69,236,945 | -116,042,087 | 69,204,899 | 69,083,127 | 39,640,826 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| Shares (Diluted) | 82,886,196 | 69,236,945 | -116,333,800 | 69,204,899 | 69,083,127 | 39,932,539 | -54,002,096 | 27,041,327 | 27,010,013 | 26,980,698 | -53,770,451 | 26,946,683 | 26,879,089 | 26,862,646 | -40,643,227 | 21,269,163 | |
| EBITDA | $-18M | $-24M | · | $-20M | $-55M | $-15M | · | $-13M | $-16M | $-19M | · | $-18M | $-20M | $-17M | · | $-15M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $35M | $38M | $38M | $145M | $228M | $29M | $31M | $41M | $54M | $63M | $69M | $68M | $34M | $39M | $135M | |
| Short-term Investments | $105M | $88M | $108M | $125M | $32M | $3M | $19M | $32M | $37M | $34M | $46M | $51M | $67M | $117M | $134M | $48M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $6M | $5M | $5M | $6M | $4M | $6M | $2M | $2M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $2M | $734.0K | |
| Prepaid Expense | $2M | $3M | $3M | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Current Assets | $192M | $126M | $149M | $165M | $179M | $233M | $61M | $77M | $93M | $103M | $125M | $133M | $145M | $165M | $180M | $190M | |
| PP&E (Net) | $1.0K | $2.0K | $3.0K | $4.0K | $9.0K | $25.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $508.0K | $457.0K | |
| PP&E (Gross) | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $377.0K | $7M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $609.0K | · | |
| Accum. Depreciation | $376.0K | $375.0K | $374.0K | $373.0K | $368.0K | $352.0K | $463.0K | $416.0K | $369.0K | $320.0K | $270.0K | $226.0K | $183.0K | $140.0K | $101.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Accounts Payable | $1M | $2M | $917.0K | $2M | $3M | $4M | $2M | $1M | $2M | $3M | $6M | $3M | $3M | $7M | $4M | $4M | |
| Accrued Liabilities | $10M | $9M | $14M | $8M | $5M | $9M | $15M | $14M | $14M | $11M | $14M | $12M | $10M | $11M | $15M | $14M | |
| Current Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $17M | $16M | $22M | $20M | $26M | $21M | $13M | $18M | $19M | $18M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $565.0K | $624.0K | $682.0K | $738.0K | $833.0K | $946.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $202.0K | $393.0K | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $11M | $11M | $15M | $10M | $9M | $12M | $18M | $17M | $23M | $21M | $27M | $21M | $20M | $25M | $26M | $25M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-392M | $-375M | $-353M | $-330M | $-312M | $-260M | $-333M | $-314M | $-302M | $-287M | $-269M | $-253M | $-236M | $-218M | $-203M | $-189M | |
| AOCI | $-63.0K | $-15.0K | $120.0K | $139.0K | $9.0K | $1.0K | $16.0K | $39.0K | $-27.0K | $-8.0K | $27.0K | $-16.0K | $-44.0K | $-32.0K | $-115.0K | $-99.0K | |
| Stockholders' Equity | $183M | $116M | $136M | $157M | $172M | $222M | $52M | $69M | $79M | $90M | $105M | $118M | $131M | $146M | $158M | $169M | |
| Liabilities + Equity | $194M | $127M | $151M | $167M | $181M | $234M | $70M | $86M | $102M | $111M | $132M | $140M | $151M | $171M | $184M | $194M | |
| Shares Outstanding | 57,009,010 | 47,196,564 | 47,145,719 | 47,128,362 | 47,128,362 | 46,784,618 | 24,680,708 | 24,614,834 | 24,614,834 | 24,554,205 | 24,554,205 | 24,525,860 | 24,519,860 | 24,436,990 | 24,435,007 | 24,395,117 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $50.0K | $44.0K | $44.0K | $43.0K | $38.0K | $46.0K | $12.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-32.0K | $0 | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $-17M | $-15M | $-53M | $-12M | $-15M | $-16M | $-9M | $-20M | $-10M | $-12M | $-17M | $-21M | $-11M | $-8M | |
| CapEx | $0 | $0 | $0 | $0 | $1.0K | $551.0K | $186.0K | $188.0K | $541.0K | $739.0K | $816.0K | $1M | $689.0K | $1M | $78.0K | $102.0K | |
| Investing Cash Flow | $-17M | $19M | $17M | $-92M | $-29M | $115M | $13M | $5M | $-4M | $11M | $4M | $13M | $51M | $16M | $-84M | $-48M | |
| Financing Cash Flow | $82M | $0 | $25.0K | $0 | $-850.0K | $95M | $53.0K | $0 | $87.0K | $-10.0K | $80.0K | $-75.0K | $313.0K | $8.0K | $-107.0K | $73M | |
| Net Change in Cash | $50M | $-3M | $-363.0K | $-107M | $-83M | $199M | $-2M | $-11M | $-13M | $-9M | $-6M | $641.0K | $34M | $-5M | $-96M | $16M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Free Cash Flow | · | $-22M | · | · | · | $-12M | · | · | · | $-20M | · | · | · | $-23M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -364.5% | · | -299.5% | -315.1% | -286.8% | · | -354.2% | |
| Net Margin | · | · | · | · | · | 1021.9% | · | -174.0% | -236.0% | -341.7% | · | -273.6% | -289.8% | -259.5% | · | -341.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -273.6% | -289.8% | · | · | -341.0% | |
| EBITDA Margin | · | · | · | · | · | -213.0% | · | -186.0% | -252.2% | -363.6% | · | -299.5% | -315.1% | -286.1% | · | -354.2% | |
| ROA | -8.9% | -12.3% | · | -14.0% | -37.3% | 42.3% | · | -11.1% | -11.5% | -13.0% | · | -9.8% | -12.8% | -9.7% | · | -8.0% | |
| ROE | -9.4% | -13.1% | · | -15.7% | -41.9% | 46.8% | · | -13.4% | -13.9% | -15.5% | · | -11.3% | -15.0% | -11.2% | · | -9.0% | |
| ROIC | -9.9% | -20.2% | · | · | · | · | · | · | · | · | · | -15.1% | -14.9% | · | · | -8.9% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.4 | 11.4 | · | 16.8 | 20.4 | 19.0 | · | 4.9 | 4.2 | 5.2 | · | 6.5 | 11.2 | 9.3 | · | 10.6 | |
| Quick Ratio | 17.2 | 11.1 | · | 16.5 | 20.2 | 18.8 | · | 4.4 | 3.8 | 4.7 | · | 6.1 | 10.7 | 8.8 | · | 10.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -336.4 | · | -307.7 | -337.0 | -290.1 | · | -259.2 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.3 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.3 | · | 1.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 2.9 | · | 1.2 | 1.3 | 1.0 | · | 1.5 | 2.2 | 1.4 | · | 3.7 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $7M | · | $14M | $21M | $26M | · | $25M | $24M | $23M | · | $22M | $20M | $16M | · | $10M | |
| Net Income TTM | $-109M | $-20M | · | $-10M | $-7M | $28M | · | $-62M | $-67M | $-68M | · | $-64M | $-66M | $-62M | · | $-134M | |
| Market Cap | $261M | $163M | · | $90M | $88M | $83M | · | $51M | $36M | $57M | · | $119M | $168M | $177M | · | $345M | |
| P/E | -3.0 | 7.0 | · | 5.4 | 26.7 | 11.9 | · | -0.9 | -0.6 | -0.9 | · | -1.9 | -2.5 | -2.6 | · | -1.2 | |
| P/S | · | 22.8 | · | 6.2 | 4.3 | 3.2 | · | 2.1 | 1.5 | 2.5 | · | 5.3 | 8.5 | 11.2 | · | 34.5 | |
| P/B | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Tangible Book | 1.4 | 1.4 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | 0.5 | 0.6 | · | 1.0 | 1.3 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -7.3 | · | · | · | -7.0 | · | · | · | -2.9 | · | · | · | -8.3 | · | · | |
| P / FCF | · | -7.3 | · | · | · | -6.7 | · | · | · | -2.8 | · | · | · | -7.8 | · | · | |
| Earnings Yield | -33.6% | 14.2% | · | 18.4% | 3.7% | 8.4% | · | -110.7% | -170.6% | -107.7% | · | -52.1% | -40.8% | -38.4% | · | -80.5% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $7M | $26M | $24M | $15M | $14M |
| Marża Operacyjna % | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% |
| Zysk netto | $-21M | $-64M | $-66M | $-61M | $-110M |
| Rozwodniony EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 10.3 | 3.6 | 4.7 | 9.6 | 9.9 |
| Wskaźnik Szybkości | 10.0 | 3.1 | 4.3 | 9.3 | 9.8 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-98M | $-61M | $-64M | $-50M | $-22M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 84 emitenci · $187.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 29 (+7 vs poprzedni kw.) | 11 (+7 vs poprzedni kw.) | 27 (+13 vs poprzedni kw.) | 13 (+5 vs poprzedni kw.) | +7.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Yu Fan | $22 264 818 | 4 861 314 | 11,87% | Akcje |
| ACUTA CAPITAL PARTNERS, LLC | $21 461 477 | 4 685 912 | 11,44% | Akcje |
| QVT Financial LP | $21 139 947 | 4 615 709 | 11,27% | Akcje |
| MONTANOVA CAPITAL, LLC | $19 694 000 | 4 300 000 | 10,50% | Akcje |
| ORBIMED ADVISORS LLC | $18 019 076 | 3 934 296 | 9,61% | Akcje |
| Avoro Capital Advisors LLC | $13 050 261 | 2 849 402 | 6,96% | Akcje |
| Siren, L.L.C. | $10 703 927 | 2 337 102 | 5,71% | Akcje |
| KVP Capital Advisors, LP | $9 920 266 | 2 165 997 | 5,29% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 359 609 | 1 388 561 | 3,39% | Akcje |
| ADAR1 Capital Management, LLC | $6 143 585 | 1 341 394 | 3,28% | Akcje |
| ACORN CAPITAL ADVISORS, LLC | $5 218 283 | 1 139 363 | 2,78% | Akcje |
| STEMPOINT CAPITAL LP | $4 676 349 | 1 021 037 | 2,49% | Akcje |
| Ally Bridge Group (NY) LLC | $3 746 161 | 817 939 | 2,00% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 495 462 | 762 997 | 1,86% | Akcje |
| Woodline Partners LP | $1 999 692 | 436 614 | 1,07% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 895 305 | 413 822 | 1,01% | Akcje |
| STATE STREET CORP | $1 772 378 | 386 982 | 0,95% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $1 742 259 | 380 406 | 0,93% | Akcje |
| Eversept Partners, LP | $1 389 141 | 303 306 | 0,74% | Akcje |
| Verdad Advisers, LP | $1 380 792 | 301 483 | 0,74% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 358 483 | 296 612 | 0,72% | Akcje |
| AMES NATIONAL CORP | $1 333 269 | 4 571 | 0,71% | Akcje |
| Balyasny Asset Management L.P. | $1 319 576 | 288 117 | 0,70% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 130 834 | 246 907 | 0,60% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 004 014 | 219 217 | 0,54% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $757 001 | 165 284 | 0,40% | Akcje |
| VANGUARD GROUP INC | $519 881 | 214 827 | 0,28% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $361 051 | 78 832 | 0,19% | Akcje |
| GOLDMAN SACHS GROUP INC | $349 060 | 76 214 | 0,19% | Akcje |
| Point72 Asset Management, L.P. | $261 651 | 57 129 | 0,14% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $237 427 | 51 840 | 0,13% | Akcje |
| Qube Research & Technologies Ltd | $224 388 | 48 993 | 0,12% | Akcje |
| UBS Group AG | $210 098 | 45 873 | 0,11% | Akcje |
| Nuveen, LLC | $200 599 | 43 799 | 0,11% | Akcje |
| Jump Financial, LLC | $186 864 | 40 800 | 0,10% | Akcje |
| DEUTSCHE BANK AG\ | $145 039 | 31 668 | 0,08% | Akcje |
| Bank of New York Mellon Corp | $132 623 | 28 957 | 0,07% | Akcje |
| WELLS FARGO & COMPANY/MN | $124 457 | 27 174 | 0,07% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $123 761 | 27 022 | 0,07% | Akcje |
| RHUMBLINE ADVISERS | $112 338 | 24 529 | 0,06% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $111 583 | 24 363 | 0,06% | Akcje |
| TWO SIGMA ADVISERS, LP | $102 608 | 42 400 | 0,05% | Akcje |
| Vanguard Global Advisers, LLC | $89 205 | 19 477 | 0,05% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $85 646 | 18 700 | 0,05% | Akcje |
| BANK OF AMERICA CORP /DE/ | $85 518 | 18 672 | 0,05% | Akcje |
| XTX Topco Ltd | $84 831 | 18 522 | 0,05% | Akcje |
| CITADEL ADVISORS LLC | $79 440 | 17 345 | 0,04% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68 434 | 14 942 | 0,04% | Akcje |
| ABG Innovation Capital Partners III GP Ltd | $64 532 | 26 666 | 0,03% | Akcje |
| CITIGROUP INC | $60 209 | 13 146 | 0,03% | Akcje |
| JPMORGAN CHASE & CO | $59 323 | 13 452 | 0,03% | Akcje |
| Invesco Ltd. | $59 261 | 12 939 | 0,03% | Akcje |
| EVERGREEN CAPITAL MANAGEMENT LLC | $50 380 | 11 000 | 0,03% | Akcje |
| Scientech Research LLC | $49 638 | 10 838 | 0,03% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $46 739 | 10 205 | 0,02% | Akcje |
| Quadrature Capital Ltd | $46 002 | 10 044 | 0,02% | Akcje |
| TWO SIGMA SECURITIES, LLC | $45 951 | 10 033 | 0,02% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $31 804 | 6 944 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $23 239 | 5 074 | 0,01% | Akcje |
| BARCLAYS PLC | $22 182 | 4 843 | 0,01% | Akcje |
| US BANCORP \DE\ | $15 265 | 3 333 | 0,01% | Akcje |
| Legal & General Group Plc | $14 482 | 3 162 | 0,01% | Akcje |
| Ameritas Investment Partners, Inc. | $13 488 | 2 945 | 0,01% | Akcje |
| Russell Investments Group, Ltd. | $11 880 | 2 594 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $11 702 | 2 555 | 0,01% | Akcje |
| BlackRock, Inc. | $11 601 | 2 533 | 0,01% | Akcje |
| OSAIC HOLDINGS, INC. | $7 048 | 1 539 | 0,00% | Akcje |
| BARTLETT & CO. WEALTH MANAGEMENT LLC | $6 105 | 1 333 | 0,00% | Akcje |
| ROYAL BANK OF CANADA | $5 000 | 1 114 | 0,00% | Akcje |
| MORGAN STANLEY | $3 490 | 762 | 0,00% | Akcje |
| Sterling Capital Management LLC | $2 995 | 654 | 0,00% | Akcje |
| SATTER MANAGEMENT CO., L.P. | $2 079 | 659 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $1 452 | 317 | 0,00% | Akcje |
| Quarry LP | $998 | 218 | 0,00% | Akcje |
| TD Waterhouse Canada Inc. | $993 | 232 | 0,00% | Akcje |
| FMR LLC | $779 | 170 | 0,00% | Akcje |
| ACADIAN ASSET MANAGEMENT LLC | $778 | 170 883 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $664 | 145 | 0,00% | Akcje |
| Integrated Wealth Concepts LLC | $604 | 132 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 26 609 | 0,00% | Akcje |
| CWM, LLC | $86 | 25 | 0,00% | Akcje |
| SIMPLEX TRADING, LLC | $82 | 18 | 0,00% | Akcje |
| Virtu Financial LLC | $66 | 14 479 | 0,00% | Akcje |
| Parallel Advisors, LLC | $37 | 8 | 0,00% | Akcje |
Insiderzy spółki 26 insiderów · 11 dyrektorzy generalni · 16 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David James Lennon | CHIEF EXECUTIVE OFFICER | 1 kwietnia 2025 A | 33 429 | 0 | 0 | $0 |
| Brendan Delaney | President and Chief Executive Officer | 1 marca 2023 A | 20 000 | 0 | 0 | $0 |
| Stephen J Hoffman | Chief Executive Officer | 14 maja 2019 A | 31 967 | 0 | 0 | $0 |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | 1 kwietnia 2025 A | 23 944 | 0 | 0 | $0 |
| Joseph H. Gardner | President | 16 marca 2020 A | 453 019 | 0 | 0 | $0 |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | 1 kwietnia 2025 A | 202 853 | 0 | 0 | $0 |
| David Dornan | Chief Scientific Officer | 4 marca 2025 A | — | 0 | 0 | $0 |
| Lorettta M Itri | CHIEF MEDICAL OFFICER | 1 marca 2024 A | — | 0 | 0 | $0 |
| Kevin G. Peters | Chief Scientific Officer and Acting Chief Medical Officer Exhibit 24: Power of Attorney | 16 marca 2020 A | 320 536 | 0 | 0 | $0 |
| Michael W Rogers | Chief Financial and Chief Business Officer | 14 maja 2019 A | — | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 15 lutego 2019 A | — | 0 | 0 | $0 |
| Baiteng Zhao | Dyrektor | 12 czerwca 2026 A | 1 250 000 | 0 | 0 | $0 |
| Neil Desai | Dyrektor | 12 czerwca 2026 A | 1 211 543 | 0 | 0 | $0 |
| Emma Reeve | Dyrektor | 12 czerwca 2026 A | — | 0 | 0 | $0 |
| Mohammad Hirmand | Dyrektor | 12 czerwca 2026 A | — | 0 | 0 | $0 |
| Anupam Dalal | Dyrektor | 12 czerwca 2026 A | 4 685 912 | 0 | 0 | $0 |
| Richard E Maroun | Dyrektor | 12 czerwca 2026 A | — | 0 | 0 | $0 |
| Caley Castelein | Dyrektor | 12 czerwca 2026 A | 274 796 | 0 | 0 | $0 |
| Karin M. Hehenberger | Dyrektor | 12 czerwca 2024 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Dyrektor | 17 czerwca 2021 A | 8 020 | 0 | 0 | $0 |
| Chau Quang Khuong | Dyrektor | 18 czerwca 2019 A | 5 193 946 | 0 | 0 | $0 |
| Satter Muneer A | Dyrektor | 18 czerwca 2019 A | 5 621 835 | 0 | 0 | $0 |
| Paul M Weiss | Dyrektor | 15 marca 2017 P | 1 576 167 | 0 | 0 | $0 |
| Dugel Pravin | — | 30 czerwca 2021 A | 12 568 | 0 | 0 | $0 |
| Steven Prelack | — | 30 czerwca 2021 A | 24 485 | 0 | 0 | $0 |
| Regina Marek | — | 16 marca 2020 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 13 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC, ANUPAM DALAL, Acuta Capital Fund, LP ×3 zgłoszenia | 18 maja 2026 | 9,00% | Aneks | Inwestycja pasywna | SEC |
| Avoro Capital Advisors LLC, Avoro Ventures LLC, Behzad Aghazadeh ×6 zgłoszenia | 14 maja 2026 | 19,99% | Aneks | — | SEC |
| Neil Desai ×5 zgłoszenia | 6 marca 2025 | 4,90% | Aneks | — | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael ×5 zgłoszenia | 5 marca 2025 | 4,98% | Aneks | Inwestycja pasywna | SEC |
| Muneer A. Satter (2) ×5 zgłoszenia | 12 listopada 2021 | — | Pierwotne zgłoszenie | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP V LLC ×4 zgłoszenia | 3 września 2021 | — | Pierwotne zgłoszenie | — | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 zgłoszenia | 15 maja 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 zgłoszenia | 4 października 2018 | — | Pierwotne zgłoszenie | — | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | 27 marca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Venture Investors Early Stage Fund IV Limited Partnership (2), VIESF IV GP LLC (2) | 27 marca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 4 kwietnia 2008 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 4 kwietnia 2008 | — | Pierwotne zgłoszenie | — | SEC |
| Argyris Vassiliou | 4 kwietnia 2008 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 10 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 23 692 SH | 21 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,04% | 112 029 SH | 21 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,01% | 311 306 SH | 20 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 28 211 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,00% | 722 832 SH | 21 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 20 759 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 470 854 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 887 972 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 187 597 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 409 SH | 19 sierpnia 2026 | Dziennie |